Founder & CEO | Molecule.one
The U.S. has outsourced critical drug production, risking national security. But AI-powered automation can bring molecule synthesis back home—boosting security, slashing costs, and revolutionizing drug discovery. The future of biotech is here.
Piotr Byrski
0
Visegrad24 is entirely funded by you, our readers—people who believe in truth, Western values, and combating disinformation.
